Innovative Pharmaceutical Biotech (0399) Financial Statements

0 Followers

Innovative Pharmaceutical Biotech Financial Overview

Innovative Pharmaceutical Biotech's market cap is currently HK$231.21M. The company's EPS TTM is HK$-0.32; its P/E ratio is -0.36; Innovative Pharmaceutical Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	HK$ 2.09M	HK$ 6.59M	HK$ 8.07M	HK$ 11.14M	HK$ 15.19M
Gross Profit	HK$ 188.00K	HK$ 840.00K	HK$ 858.00K	HK$ 1.05M	HK$ 1.41M
Operating Income	HK$ -13.26M	HK$ -13.43M	HK$ -20.70M	HK$ -24.35M	HK$ -21.34M
EBITDA	HK$ -296.99M	HK$ 317.75M	HK$ -18.82M	HK$ 228.51M	HK$ -18.81M
Net Income	HK$ -345.94M	HK$ 103.40M	HK$ -245.70M	HK$ 296.54M	HK$ -395.75M
Balance Sheet
Cash & Short-Term Investments	HK$ 3.70M	HK$ 3.08M	HK$ 1.33M	HK$ 4.08M	HK$ 8.99M
Total Assets	HK$ 1.09B	HK$ 1.38B	HK$ 1.38B	HK$ 1.39B	HK$ 1.40B
Total Debt	HK$ 1.00B	HK$ 1.01B	HK$ 1.19B	HK$ 941.84M	HK$ 991.48M
Net Debt	HK$ 999.77M	HK$ 1.01B	HK$ 1.19B	HK$ 937.76M	HK$ 982.49M
Total Liabilities	HK$ 1.06B	HK$ 1.06B	HK$ 1.24B	HK$ 999.73M	HK$ 1.04B
Stockholders' Equity	HK$ -681.19M	HK$ -611.51M	HK$ -795.07M	HK$ -549.37M	HK$ -595.35M
Cash Flow
Free Cash Flow	HK$ -10.55M	HK$ -8.28M	HK$ -17.64M	HK$ -12.34M	HK$ -25.01M
Operating Cash Flow	HK$ -10.55M	HK$ -8.28M	HK$ -17.64M	HK$ -12.34M	HK$ -25.01M
Investing Cash Flow	HK$ 0.00	HK$ 0.00	HK$ 0.00	HK$ -1.00K	HK$ 13.00K
Financing Cash Flow	HK$ 11.19M	HK$ 10.32M	HK$ 14.92M	HK$ 7.30M	HK$ 10.57M

Currency in HKD

Innovative Pharmaceutical Biotech Earnings and Revenue History

Income Statement >

Innovative Pharmaceutical Biotech Liabilities to Assets

Balance Sheet >

Innovative Pharmaceutical Biotech Cash Flow

Cash Flow >

Innovative Pharmaceutical Biotech Forecast EPS vs Actual EPS

Earnings >

Innovative Pharmaceutical Biotech financials statements